Neogen (NEOG) Director Tobin Converts 2,071 RSUs to Shares
Rhea-AI Filing Summary
Tobin James P, a director of Neogen Corp (NEOG), had 2,071 restricted stock units vest on 10/07/2025 and those RSUs were settled into 2,071 shares of common stock at a recorded price of $5.63 per share. After the settlement, the reporting person beneficially owned 39,545 shares directly. The Form 4 shows this as an acquisition resulting from compensation vesting rather than an open-market purchase.
Positive
- 2,071 RSUs vested into common stock on 10/07/2025, aligning director compensation with shareholders
- Beneficial ownership increased to 39,545 shares, reflecting continued insider stake
Negative
- None.
Insights
Director RSU vesting added 2,071 shares; change is routine compensation.
Vesting of 2,071 RSUs converted to the same number of common shares at an indicated per-share price of $5.63, increasing the director's direct holdings to 39,545 shares. This is recorded as an acquisition under Section 16 and reflects equity-based compensation delivered as equity rather than cash.
The primary dependencies are standard vesting terms and the company’s equity plan; no sale or disposition is disclosed here. Near-term investor impact is minimal given the modest share count, but monitor future Forms for any subsequent sales or additional grants within the next 12 months.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 2,071 | $5.63 | $12K |
| Exercise | Common Stock | 2,071 | $5.63 | $12K |
FAQ
What did the NEOG Form 4 filed for Tobin James P report?
Was this Form 4 transaction a market purchase or a compensation vesting (NEOG)?
AI-generated analysis. How Rhea-AI works. Not financial advice.